Amino acid · Fact sheet
Glycine
Glycine is an amino acid with small human studies of sleep and next-day fatigue. These early results do not establish treatment of chronic insomnia or the benefits of glycine alone for healthy aging.
What is Glycine?
Glycine is a building block for proteins and glutathione and also participates in nervous-system signaling. Being naturally present in the body does not settle the benefits or risks of supplementation.
Benefits & claims
Better sleep, reduced next-day fatigue, collagen support, and healthy aging drive interest. Studies combining glycine with N-acetylcysteine cannot isolate glycine’s contribution.
What the evidence supports
- Small studies reported improved subjective sleep or reduced next-day fatigue in selected conditions.
- These results do not establish a treatment for chronic insomnia or prove an anti-aging benefit.
Research areas
- Sleep quality
- Daytime fatigue after sleep restriction
- Glutathione-related metabolism
Dosage & frequency
Human study contextA small sleep-restriction experiment provides an oral study amount. It is not a validated long-term insomnia treatment schedule.
Sleep-restriction crossover experiment
Seven analyzed healthy adults under short-term sleep restriction
- Amount
- 3 g
- Frequency
- Thirty minutes before bedtime on three study nights
- Route studied or labeled
- Oral
Small short-term study; not a chronic insomnia prescription.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
Formulation differences
- The study examined glycine alone, not a GlyNAC combination.
Interactions & precautions
- The small sleep study does not establish a comprehensive interaction profile with sleep medicines or other CNS-active substances.
What is still unresolved
- Long-term effects in clinical insomnia and different sleep disorders remain uncertain.
Side effects & risks
- The short sleep studies cannot establish uncommon adverse effects or long-term safety.
- Safety and effects of multi-ingredient products cannot be inferred from isolated-glycine studies.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Early human evidenceThe sleep literature cited here uses small, short experiments, including sleep restriction. Findings on subjective fatigue or a laboratory sleep night need confirmation in larger clinical populations.
Studies
Small short-term human experiment; animal circadian experiments reported separately.
Small human sleep study published in Sleep and Biological Rhythms.
Bannai et al., 2012; same study as PMID22529837, with three-night 3 g exposure in healthy volunteers.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
Explore 4 sourced accounts by reported effect.
Energy: reported experiences
Earlier waking and afternoon tiredness
Another person described shorter sleep and afternoon fatigue after starting glycine, then more usual sleep on a day without it.
Reported use in this account
- Product
- Product described as glycine
- Amount
- 3 grams
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- About three days
Other exposures described: Vimpat and low-dose escitalopram
The poster also described irregular sleep, epilepsy and prescription medicines. These confounders prevent a confident causal conclusion.
Read the contrasting sleep accountSleep: reported experiences
More daytime calm with an unpleasant night
An author described feeling calmer and slightly more focused after their first glycine experience, but also unusually vivid dreams, interrupted sleep and difficulty waking. They wondered whether some episodes were sleep paralysis.
Reported use in this account
- Product
- Product described as glycine
- Amount
- About 2.5 grams on each of two reported occasions
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Not specified clearly
The source gives inconsistent clock-time wording, so a precise schedule cannot be resolved. The dreamlike experiences and possible sleep paralysis were not clinically assessed, and the author already had irregular sleep.
Read the original accountMore consistently restorative sleep
A person with recurring sleep difficulties described more good nights and subjectively deeper, more restorative sleep after starting glycine.
Reported use in this account
- Product
- Glycine powder
- Amount
- Estimated 4–5 grams; the author says this was half a supplied scoop
- Frequency
- Not specified clearly
- Route
- Oral
- Duration
- A few weeks before noticing a change
Sleep stages were not independently measured. The report is unblinded and does not establish treatment of a sleep disorder.
Read the positive sleep accountEarlier waking and afternoon tiredness
Another person described shorter sleep and afternoon fatigue after starting glycine, then more usual sleep on a day without it.
Reported use in this account
- Product
- Product described as glycine
- Amount
- 3 grams
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- About three days
Other exposures described: Vimpat and low-dose escitalopram
The poster also described irregular sleep, epilepsy and prescription medicines. These confounders prevent a confident causal conclusion.
Read the contrasting sleep accountNo definite sleep effect after months of nightly exposure
A commenter with severe sleep difficulties described no definite effect from nightly glycine over about six months. They had reduced the number of capsules and reported several other sleep-related medicines or substances.
Reported use in this account
- Product
- Product described as glycine capsules
- Amount
- Three 1,000 mg capsules initially; one 1,000 mg capsule more recently
- Frequency
- Every night
- Route
- Not specified clearly
- Duration
- About six months
Other exposures described: Doxepin; Lemborexant; Baclofen; CBD
Severe underlying sleep problems and other reported exposures limit interpretation. The source does not explicitly state a route, verify capsule contents or measure a glycine-specific effect.
Read the nightly-use accountMood: reported experiences
More daytime calm with an unpleasant night
An author described feeling calmer and slightly more focused after their first glycine experience, but also unusually vivid dreams, interrupted sleep and difficulty waking. They wondered whether some episodes were sleep paralysis.
Reported use in this account
- Product
- Product described as glycine
- Amount
- About 2.5 grams on each of two reported occasions
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Not specified clearly
The source gives inconsistent clock-time wording, so a precise schedule cannot be resolved. The dreamlike experiences and possible sleep paralysis were not clinically assessed, and the author already had irregular sleep.
Read the original accountFocus: reported experiences
More daytime calm with an unpleasant night
An author described feeling calmer and slightly more focused after their first glycine experience, but also unusually vivid dreams, interrupted sleep and difficulty waking. They wondered whether some episodes were sleep paralysis.
Reported use in this account
- Product
- Product described as glycine
- Amount
- About 2.5 grams on each of two reported occasions
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Not specified clearly
The source gives inconsistent clock-time wording, so a precise schedule cannot be resolved. The dreamlike experiences and possible sleep paralysis were not clinically assessed, and the author already had irregular sleep.
Read the original accountNo clear change: reported experiences
No definite sleep effect after months of nightly exposure
A commenter with severe sleep difficulties described no definite effect from nightly glycine over about six months. They had reduced the number of capsules and reported several other sleep-related medicines or substances.
Reported use in this account
- Product
- Product described as glycine capsules
- Amount
- Three 1,000 mg capsules initially; one 1,000 mg capsule more recently
- Frequency
- Every night
- Route
- Not specified clearly
- Duration
- About six months
Other exposures described: Doxepin; Lemborexant; Baclofen; CBD
Severe underlying sleep problems and other reported exposures limit interpretation. The source does not explicitly state a route, verify capsule contents or measure a glycine-specific effect.
Read the nightly-use accountApproval status
Glycine has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.
Supplement research is not FDA drug approval
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Durable improvement in diagnosed sleep disorders
- Long-term outcomes from glycine alone
- Effects in different age groups and with other medicines
Summary
These results do not establish a treatment for chronic insomnia or prove an anti-aging benefit.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- pubmedGlycine and daytime performance after sleep restriction
Small short-term human experiment; animal circadian experiments reported separately.
- journalGlycine and subjective and polysomnographic sleep measures
Small human sleep study published in Sleep and Biological Rhythms.
- fdaFDA: what approval means for supplements
Dietary supplements are not approved by FDA for safety and effectiveness before marketing.
- journalOriginal glycine sleep-restriction experiment: full text
Bannai et al., 2012; same study as PMID22529837, with three-night 3 g exposure in healthy volunteers.